Kuidas keskusega ühendust võtta
HCP keskus
Umbes 14.100 XNUMX töötajaga on UKE Hamburgi vaba- ja hansalinna suuruselt kolmas tööandja.
Uurimistöö UKE-s
Uuringud on diagnostika ja ravi edusammude oluline eeltingimus. UKE uurimistöös on rõhk neuroteadustel, kardiovaskulaarsetel uuringutel, hooldusuuringutel, onkoloogial, aga ka infektsioonidel ja põletikel. Teised UKE potentsiaalsed valdkonnad on molekulaarpildistamine ja skeletibioloogia uuringud.
Saada sõnum
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
meeskond
Pr Martin Spitzer
Saksamaa
Dr Johannes Birtel
Saksamaa
Kliinilised uuringud
A Phase 3, Randomized, International Multicenter Trial of DAY101 Monotherapy Versus Standard of Care Chemotherapy in Patients with Pediatric Low-Grade Glioma Harboring an Activating RAF Alteration Requiring First-Line Systemic Therapy
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis
Long-Term Non-Interventional Latanoprost Study
European Disease Registry on Retinopathy of Prematurity (ROP)
Early Reperfusion Therapy With Intravenous Alteplase for Recovery of VISION in Acute Central Retinal Artery Occlusion
A Phase III, Multicentre, International Study With a Parallel, Randomised, Double-blind, Placebo-controlled, 2 Arm Design to Assess the Efficacy and Safety of Selumetinib in Adult Participants With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas (KOMET)
An Open-label, Active-Controlled, Safety, and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Active Juvenile Idiopathic Arthritis-Associated Uveitis or Chronic Anterior Antinuclear Antibody-Positive Uveitis